BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25771896)

  • 1. Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
    Bellido E; Hidalgo T; Lozano MV; Guillevic M; Simón-Vázquez R; Santander-Ortega MJ; González-Fernández Á; Serre C; Alonso MJ; Horcajada P
    Adv Healthc Mater; 2015 Jun; 4(8):1246-57. PubMed ID: 25771896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
    Unamuno X; Imbuluzqueta E; Salles F; Horcajada P; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2018 Nov; 132():11-18. PubMed ID: 30179739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-covalent "click chemistry" strategy to efficiently coat highly porous MOF nanoparticles with a stable polymeric shell.
    Aykaç A; Noiray M; Malanga M; Agostoni V; Casas-Solvas JM; Fenyvesi É; Gref R; Vargas-Berenguel A
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1606-1616. PubMed ID: 28137620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A "green" strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles.
    Agostoni V; Horcajada P; Noiray M; Malanga M; Aykaç A; Jicsinszky L; Vargas-Berenguel A; Semiramoth N; Daoud-Mahammed S; Nicolas V; Martineau C; Taulelle F; Vigneron J; Etcheberry A; Serre C; Gref R
    Sci Rep; 2015 Jan; 5():7925. PubMed ID: 25603994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-Coated Photosensitive Metal-Organic Frameworks as Drug Delivery Nanoplatforms of Autophagy Inhibitors for Sensitized Photodynamic Therapy against Breast Cancer.
    Sun Q; Hou X; Yang J; Zhang M; Yang Y; Liu Y; Shen W; Yin D
    ACS Appl Mater Interfaces; 2021 Nov; 13(46):55577-55590. PubMed ID: 34762394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers.
    Hidalgo T; Giménez-Marqués M; Bellido E; Avila J; Asensio MC; Salles F; Lozano MV; Guillevic M; Simón-Vázquez R; González-Fernández A; Serre C; Alonso MJ; Horcajada P
    Sci Rep; 2017 Mar; 7():43099. PubMed ID: 28256600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porous nanoparticles with engineered shells release their drug cargo in cancer cells.
    Qiu J; Li X; Rezaei M; Patriarche G; Casas-Solvas JM; Moreira-Alvarez B; Costa Fernandez JM; Encinar JR; Savina F; Picton L; Vargas-Berenguel A; Gref R
    Int J Pharm; 2021 Dec; 610():121230. PubMed ID: 34718091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Loaded Lipid-Coated Hybrid Organic-Inorganic "Stealth" Nanoparticles for Cancer Therapy.
    Li X; Salzano G; Qiu J; Menard M; Berg K; Theodossiou T; Ladavière C; Gref R
    Front Bioeng Biotechnol; 2020; 8():1027. PubMed ID: 33042960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porous metal organic framework nanoparticles to address the challenges related to busulfan encapsulation.
    Chalati T; Horcajada P; Couvreur P; Serre C; Ben Yahia M; Maurin G; Gref R
    Nanomedicine (Lond); 2011 Dec; 6(10):1683-95. PubMed ID: 22122581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the colloidal stability of the mesoporous MIL-100(Fe) nanoparticles in physiological media.
    Bellido E; Guillevic M; Hidalgo T; Santander-Ortega MJ; Serre C; Horcajada P
    Langmuir; 2014 May; 30(20):5911-20. PubMed ID: 24801765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Engineered Cyclodextrin Derivatives for Spontaneous Coating of Highly Porous Metal-Organic Framework Nanoparticles in Aqueous Media.
    Cutrone G; Li X; Casas-Solvas JM; Menendez-Miranda M; Qiu J; Benkovics G; Constantin D; Malanga M; Moreira-Alvarez B; Costa-Fernandez JM; García-Fuentes L; Gref R; Vargas-Berenguel A
    Nanomaterials (Basel); 2019 Aug; 9(8):. PubMed ID: 31374940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards improved HIV-microbicide activity through the co-encapsulation of NRTI drugs in biocompatible metal organic framework nanocarriers.
    Marcos-Almaraz MT; Gref R; Agostoni V; Kreuz C; Clayette P; Serre C; Couvreur P; Horcajada P
    J Mater Chem B; 2017 Nov; 5(43):8563-8569. PubMed ID: 32264524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient "green" encapsulation of a highly hydrophilic anticancer drug in metal-organic framework nanoparticles.
    Rodriguez-Ruiz V; Maksimenko A; Anand R; Monti S; Agostoni V; Couvreur P; Lampropoulou M; Yannakopoulou K; Gref R
    J Drug Target; 2015; 23(7-8):759-67. PubMed ID: 26453171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the genistein oral bioavailability
    Botet-Carreras A; Tamames-Tabar C; Salles F; Rojas S; Imbuluzqueta E; Lana H; Blanco-Prieto MJ; Horcajada P
    J Mater Chem B; 2021 Mar; 9(9):2233-2239. PubMed ID: 33596280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GraftFast Surface Engineering to Improve MOF Nanoparticles Furtiveness.
    Giménez-Marqués M; Bellido E; Berthelot T; Simón-Yarza T; Hidalgo T; Simón-Vázquez R; González-Fernández Á; Avila J; Asensio MC; Gref R; Couvreur P; Serre C; Horcajada P
    Small; 2018 Oct; 14(40):e1801900. PubMed ID: 30091524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
    Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Characterization Methodology to Unravel the Biodegradability of Metal-Organic Framework Nanoparticles in Extremely Diluted Conditions.
    Christodoulou I; Patriarche G; Serre C; Boissiére C; Gref R
    ACS Appl Mater Interfaces; 2024 Mar; 16(11):14296-14307. PubMed ID: 38452344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pushing the Limits on the Intestinal Crossing of Metal-Organic Frameworks: An
    Rojas S; Hidalgo T; Luo Z; Ávila D; Laromaine A; Horcajada P
    ACS Nano; 2022 Apr; 16(4):5830-5838. PubMed ID: 35298121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biocompatibility of mesoporous metal (III; Fe, Al, Cr) trimesate MOF nanocarriers.
    Grall R; Hidalgo T; Delic J; Garcia-Marquez A; Chevillard S; Horcajada P
    J Mater Chem B; 2015 Nov; 3(42):8279-8292. PubMed ID: 32262883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-Independent Robust and Heparin-Mimetic Hydrogel Thin Film Coating via Combined LbL Self-Assembly and Mussel-Inspired Post-Cross-linking.
    Ma L; Cheng C; He C; Nie C; Deng J; Sun S; Zhao C
    ACS Appl Mater Interfaces; 2015 Dec; 7(47):26050-62. PubMed ID: 26553500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.